Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Adverse Events from ACEIs
This patient is sent home with his medications and the consumer summary guide (“ACE Inhibitors” and “ARBs” To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease), which he can continue to refer to in the event of questions.
In six weeks, he returns to your office with a dry persistent cough that keeps him up at night.
He has been referring to the the consumer summary guide and wonders if there are any other drugs he can take to help him.
- ACE Inhibitors” and “ARBs” To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease. Rockville, MD: Agency for Healthcare Research and Quality. AHRQ Pub. No. 10-EHC002-A. May 2010.
- Coleman CI, Baker WL, Kluger J, et al. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease. Comparative Effectiveness Review No. 18 (Prepared by the University of Connecticut/Hartford Hospital Evidence-based Practice Center under Contract No. 290-2007-10067-I). Rockville, MD: Agency for Healthcare Research and Quality; October 2009.
Your slide tray is being processed.